CDK6 and leukemia: Notably, MECOM-r cases associated with CDK6 showed fusion junctions in intron 2 or 3 of CDK6 (Supplementary Fig. S6E), suggesting these leukemias are utilizing alternative enhancers within the CDK6 locus other than CDK6-AS1.